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ABSTRACT We have used a "plug and socket" targeting
technique to generate a mouse model of 130-thalassemia in
which both the bi and b2 adult globin genes have been deleted.
Mice homozygous for this deletion (Hbbth-3/Hbbth-3) die peri-
natally, similar to the most severe form of Cooley anemia in
humans. Mice heterozygous for the deletion appear normal,
but their hematologic indices show characteristics typical of
severe thalassemia, including dramatically decreased hemat-
ocrit, hemoglobin, red blood cell counts, mean corpuscular
volume, mean corpuscular hemoglobin, and mean corpuscular
hemoglobin concentration, as well as dramatically increased
reticulocyte counts, serum bilirubin concentrations, and red
cell distribution widths. Tissue and organ damage typical of
f3-thalassemia, such as bone deformities and splenic enlarge-
ment due to increased hematopoiesis, are also seen in the
heterozygous animals, as is spontaneous iron overload in the
spleen, liver, and kidneys. The mice homozygous for the bi and
b2 deletions should be of great value in developing therapies
for the treatment of thalassemias in utero. The heterozygous
animals will be useful for studying the pathophysiology of
thalassemias and have the potential of generating a model of
sickle cell anemia when mated with appropriate transgenic
animals.
The a- and ,B-globin polypeptide chains of hemoglobin are
encoded by multigene clusters that are generally conserved
throughout mammalian evolution. The mouse 3-globin gene
cluster on chromosome 7 (1) has four functional ,B-globin
genes: O3hl, an early embryonic globin gene; sy2, a late embry-
onic globin gene; and two adult globin genes, bl (/3major) and
b2 ((3minor) (2). Mouse embryonic hemoglobins are first ex-
pressed at 9.5 days of gestation in the yolk sac and later in fetal
liver. The switch from predominantly embryonic to predom-
inantly adult hemoglobins is completed between days 14 and
15 of gestation in the normal fetus (3, 4). The bl and b2 genes
are then expressed in fetal liver and spleen and, finally, in bone
marrow during adult life. The bi gene is reported to be
responsible for 80% and b2 for 20% of adult ,B-globin
production (5).
Human thalassemias are a heterogeneous group of inherited
disorders of hemoglobin synthesis, all characterized by the
absence of or reduction in amounts of one or more of the
globin chains of hemoglobin (6), which generates an imbalance
between the subunits of hemoglobin. When the reduction is
among the adult ,B-globin genes, the resultant disorders are
f3-thalassemias. These disorders can be divided into two major
groups, (30 and f3+, based on the quantity of /3-globin produced;
f31(-thalassemia results from the complete absence of the
3-globin, and l3+-thalassemia results from a decrease in ,B-glo-
bin production.
No naturally occurring 30-thalassemia has been observed in
mice, but two mouse models of f3+-thalassemia exist (7, 8). In
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the first, a spontaneous DNA deletion of -3.7 kb in the
,3-globin locus was found that includes the entire bl gene and
its adjacent upstream sequences. Mice homozygous for the
deletion (Hbbth-l/Hbbth-l) survive to adulthood in 60% of the
numbers with wild-type (wt) mice. The heterozygous mice exhibit
a mild phenotype comparable to that of thalassemia trait in
humans (7). The second model for ,B-thalassemia was created by
targeted gene disruption of the mouse bl gene. Mice homozygous
for an insertional disruption of the bl gene (Hbbth-2/Hbbth-2) are
severely anemic and do not survive more than a few hours after
birth (8). A possible explanation for the difference between the
deletion and disruption mouse models of thalassemia is that
the non-globin-producing promoters in the disrupted /3-globin
locus can compete for access to the locus control region
needed for transcription, thereby reducing transcription from
the normal b2 gene (8). In the deletion animals, the b2 gene
has no competitors. Similar differences in transcription have
been observed in human thalassemic patients with deletions or
mutations in the promoter region of the adult f-globin gene
compared to patients with deletions or mutations that do not
affect the promoter region (9).
The mice homozygous for deletion of both bi and b2 genes
that we have generated in the present study have a severe form
of ,B0-thalassemia, similar to the most severe forms of Cooley
anemia in humans. The heterozygous animals show a patho-
physiology comparable to that of patients with classical human
,B-thalassemia intermedia.
MATERIALS AND METHODS
Animals. All the wt mice and mice heterozygous for the
,B-globin gene deletion studied here are F1 animals, except
where stated otherwise. The F1 animals are offspring from
mating between chimeras and mice of strain C57BL/6J (strain
B6) and they have a hybrid genetic background derived from
the two inbred strains: B6 and 12901a (strain 129). All mice
were maintained in a room illuminated from 7 a.m. to 7 p.m.
and were fed and watered ad libitum.
Gene Targeting. Deletion of the mouse bl and b2 adult
,3-globin genes was accomplished by the two-step "plug and
socket" gene targeting strategy as described (10). Three inde-
pendently targeted embryonic stem (ES) cells were injected
into host B6 blastocysts (11). Chimeric mice generated from
two of them transmitted the targeted gene to their offspring.
Mice heterozygous for the deletion have diagnostic bands of
13.0 or 12.4 kb when genomic DNA is digested with Xba I or
Hpa I, Southern blotted, and probed with a 500-bp HPRT gene
fragment containing the HPRT promoter and the first exon
(10).
Collection and Hematologic Analysis of Blood. Blood sam-
ples were collected from the retroorbital sinus. For hemoglo-
bin analysis, freshly drawn, heparinized blood samples were
collected, and the red cells were washed once in 20X vol of
phosphate-buffered saline and lysed in 5x vol of cystamine-
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containing buffer (12). Samples containing approximately
equal amounts of hemoglobin were then run on cellulose
acetate membranes (Helena Laboratories) (12). Hemoglobin
bands were visualized by Ponceau S staining (Helena Labo-
ratories).
For hematologic analyses, freshly drawn EDTA-treated
blood was used. Peripheral blood smears were stained with
Wright's stain (Sigma). Hematologic profiles were obtained
with an automatic blood cell counter (Roche Cobas Helios
Hematology Analyzer), which gives complete blood cell counts.
Reticulocyte counts following supravital staining with Ac-
custain (1% new methylene blue/0.9% sodium chloride/1.6%
potassium oxalate) (Sigma) were determined by standard
methods (13). Serum bilirubin concentrations (total and di-
rect) were determined on freshly collected blood using a
reagent kit (procedure no. 605) from Sigma.
Scanning electron microscopy was performed on freshly
drawn, heparinized blood samples. After washing once with
saline, packed red blood cells were fixed with glutaraldehyde
and allowed to settle on polylysine-coated glass coverslips.
Blood cells were then dehydrated in a graded series of ethanol
and critical-point dried. After drying, blood cells were coated
with carbon followed by a 60:40 mixture of gold/palladium for
viewing with a Cambridge scanning electron microscope at 10
kV.
Histology. Mice for histologic studies were sacrificed with a
lethal dose of tribromoethanol (Avertin). The abdominal and
thoracic cavities were opened and visceral organs were per-
fused through heart puncture with phosphate-buffered para-
formaldehyde (4%; pH 7.4) under physiological pressure.
Spleen, liver, heart, lungs, and kidneys were removed, weighed,
embedded, and sectioned. Specimens were stained with he-
matoxylin and eosin and iron stains (Prussian blue).
Skulls and left femora from wt and heterozygous animals
were removed, decalcified, embedded, and sectioned for his-
tologic assessment by hematoxylin and eosin staining.
Statistical Analysis. The two independent samples t test was
used (SYSTAT; see ref. 14) for comparing hematologic values
between wt and heterozygous mice.
RESULTS AND DISCUSSION
Generation of ,3-Thalassemic Mice. In an earlier study from
our laboratory, Detloff et al. (10) generated two targeted ES
cell lines that had both the mouse adult ,B-globin genes (bi and
b2) deleted. The deletion plug P3Aplugl.5 was also reinserted
into the socket-containing ES cell line B20 as described (10),
and Southern blot analysis revealed the presence of the desired
deletion in one of six hypoxanthine/aminopterin/thymidine-
resistant colonies. The three targeted ES cell lines were used
to generate chimeric animals by injection into host blastocysts.
Of 10 chimeras generated from two of the three targeted ES
cell lines, two males and two females transmitted the ES cell
genome to their offspring after being mated to mice of strain
B6. The resulting (B6 x 129)F1 hybrids were initially geno-
typed by Southern blot analysis for the bl and b2 globin gene
deletion using genomic DNA from tail biopsies. Subsequently,
heterozygotes were genotyped by blood smears, since their
smears were so different from those of wt mice.
Body Weight Difference. The F, heterozygotes at the time of
birth are pale and small in comparison with their wt litter-
mates. At weaning (3 weeks), significant differences (P <
0.005) in body weight between F1 heterozygotes and male or
female F1 wt animals were observed (Table 1). Body weight
differences between wt F2 and heterozygous F2 pups at wean-
ing are smaller although still significant (P < 0.05, if all mice,
both male and female, are compared; see Table 1). Body
weight differences in the F, mice decreased with age, becoming
statistically insignificant by 8-10 weeks of age (data not
shown).
Homozygous Animals. Eight intercrosses between F1 het-
erozygotes yielded 45 pups and 5 stillborn animals. Seven
live-born pups were extremely pale and died within 12 hr. All
7 mice dying within 12 hr and the 5 stillborn ones were
determined to be homozygous for the bi and b2 deletions. The
overall numbers of each genotype were not statistically differ-
ent from Mendelian expectations (15 wt, 23 heterozygotes, and
12 homozygotes; P 0.7; x2 analysis). The mice homozygous
for the bi and b2 deletions resemble human patients with the
transfusion-dependent homozygous forms of ,B0-thalassemia
that are lethal in the untreated state. They differ from humans
in that they die within hours after birth rather than later in
childhood. The increased severity of the phenotype in mice
probably occurs because the genetic switch from embryonic to
adult hemoglobin occurs 7-8 days before birth in mice. In
humans, the switch from synthesizing fetal to adult hemoglobin
is not completed until several months to a year after birth, and
untransfused human f311-thalassemia homozygotes die in late
infancy (15).
Red Cell Morphology. Blood smears (data not shown) and
scanning electron micrographs (Fig. 1) were obtained using the
blood of wt and heterozygous mice 7 weeks of age. The
heterozygotes show characteristics typical of those seen in
patients with severe thalassemia. There is marked anisocytosis
and poikilocytosis; there are many microcytes, occasional
polychromatic macrocytes, and frequent target cells. The red
cells are generally hypochromic with variable numbers of
teardrop and oval forms, and fragmented cells are seen.
Nucleated red blood cells are also present. Pappenheimer
bodies from precipitated a-globin chains are seen in the red
blood cells.
Hematologic Studies. Hematologic studies included mea-
surements of total hemoglobin, red blood cell count, hemat-
ocrit, reticulocyte count, and serum bilirubin concentrations
(total and indirect) on wt and heterozygous mice 6-7 weeks of
age. A summary of the results is shown in Table 2. Mice
heterozygous for the deletion are anemic, as is reflected in the
markedly decreased hematocrit, hemoglobin concentration,
and red blood cell count. Their reticulocyte counts are dra-
matically increased (21-fold), indicating a state of active
erythropoiesis in the heterozygous animals. The elevated
serum concentrations of total and indirect bilirubin in het-
erozygous animals indicate an increased rate of red blood cell
turnover and hemolysis. The high reticulocyte counts, low red
blood cell counts, and increased indirect bilirubin in heterozy-
gous mice indicate that both production and destruction of
erythrocytes are increased in heterozygous compared to wt
mice.
Table 1. Body weight of weanlings
F1 cross F2 cross
All mice Male Female All mice Male Female
wt 11.8 + 0.4 (n = 24) 11.7 + 0.6 (n = 14) 12.0 + 0.4 (n = 10) 9.2 + 0.3 (n = 47) 9.1 + 0.3 (n = 31) 10.1 + 0.5 (n = 16)
Heterozygotes 9.0 + 0.6 (n = 18) 8.7 + 0.7 (n = 10) 9.4 ± 0.6 (n = 8) 8.5 + 0.2 (n = 39) 8.5 ± 0.3 (n = 23) 8.4 ± 0.3 (n = 16)
P 0.00001 0.003 0.001 0.044 0.218 0.009
Body weights are expressed as means + SEM.
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FIG. 1. Scanning electron micrograph of blood cells from a heterozygous F1 13-thalassemic mouse and a wt littermate at 7 weeks of age. (A)
wt mouse. (B) Mouse heterozygous for bl and b2 deletions. (X5390.)
Human thalassemic patients have a characteristic hypochro-
mic, microcytic anemia, with decreased mean corpuscular
volume, mean corpuscular hemoglobin, and mean corpuscular
hemoglobin concentration and increased red cell distribution
width (15). Mice heterozygous for the bl and b2 gene deletions
have similar changes (Table 2) in all these parameters.
Hemoglobin Electrophoresis. The absence of 13-globin pro-
duction from the altered strain 129-derived ,B-globin locus was
established by studying animals heterozygous for a normal
3-globin locus that directs synthesis of a distinguishable form
of adult ,3-globin. Hemoglobin from F1 heterozygous animals
have a wt (HbbS haplotype) chromosome from B6 and the
strain 129-derived deletion chromosome, which would nor-
mally direct the synthesis of major and minor ,B-globin (Hbbd
haplotype). When cystamine-modified hemoglobins are sepa-
rated by cellulose acetate electrophoresis (12), wt (B6 x
129)F1 mice have the B6-derived single and the 129-derived
major and minor ,B-globin (Fig. 2, lane 2). The heterozygous
thalassemic mice have only the B6-derived single ,B-globin
(lane 3), verifying that the deletion chromosome contributed
no adult ,B-globin chains (5).
Pathology and Histology. Pathologic changes revealed by
gross and microscopic examination of the heterozygous ani-
mals were similar to those of human patients with severe
thalassemia. Spleen, liver, heart, lung, and kidney weights were
determined as ratios to total body weight for both wt and
heterozygous mutant animals. There were no differences in
these ratios for liver, heart, lungs, and kidneys between wt and
heterozygous animals. There was, however, a highly significant
increase (P < 0.001) in the spleen weight/body weight ratio
from heterozygous animals compared to wt control mice (2.80
± 0.24 mg/g for wt mice versus 21.61 ± 4.54 mg/g for
thalassemic mice). Splenomegaly is a common feature in
human thalassemia patients.
Histologic studies of the heterozygotes also revealed signif-
icant changes. Again the most dramatic changes appeared to
be in the spleens of the animals due to increased extramed-
ullary hematopoiesis (Fig. 3). Spleen sections of wt mice show
the typical normal histology with distinct red and white pulp
in approximately equal proportions, with the white pulp-
containing follicles having germinal centers and the red pulp
having hematopoietic cells. Megakaryocytes are present in the
red pulp, and trabeculae can be seen. In the spleens from mice
heterozygous for the bl and b2 deletions, there is no clear
distinction between red and white pulp. Instead, the white pulp
is almost completely replaced by hematopoietic tissue, and
there is impressive erythroid hyperplasia. Occasional germinal
centers can be seen perivascularly. More megakaryocytes are
Table 2. Hematologic values
RBC, MCV, MCHC, Bilirubin, mg/dl
Hct, % Hb, g/dl 106/mm3 Retics, % gm3 MCH, pg g/dl RDW Total Indirect
wt F1 45.7 ± 0.8 16.5 ± 0.5 9.5 ± 0.4 1.4 ± 0.4 51.1 ± 0.2 18.6 ± 0.2 365 ± 0.4 17.4 ± 0.6 0.18 ± 0.07 0.14 + 0.03
(n = 30) (n = 28) (n =27) (n =5) (n = 18) (n = 18) (n = 18) (n = 18) (n =10) (n =10)
Heterozygous F1 30.5 ± 0.8 10.9 ± 0.3 6.6 ± 0.1 30.3 ± 0.9 43.0 ± 0.5 17.6 ± 0.4 30.7 ± 0.4 46.1 ± 0.5 0.45 ± 0.06 0.36 + 0.07
(n = 28) (n = 28) (n =24) (n =4) (n = 17) (n = 17) (n = 17) (n = 17) (n =7) (n =7)
P <0.00001 <0.00001 <0.00001 <0.00001 <0.00001 0.014 <0.00001 <0.00001 0.00004 0.00004
% changes -33 -34 -31 2064 -16 -5 -16 165 150 157
Hematologic 'values are expressed as means ± SEM. Hct, hematocrit; RBC, red blood cells; Retics, reticulocytes; MCV, mean corpuscular volume;
MCH, mean corpuscular hemoglobin; MCHC, MCH concentration; RDW, red cell distribution width.
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FIG. 2. Cellulose acetate electrophoretic analyses of mouse hemo-
globins. Cystamine-modified hemoglobin was electrophoresed on cel-
lulose acetate gel. Lanes 1-4, hemoglobins from wt mice of strain B6,
wt F1 mice, F1 mice heterozygous for bl and b2 deletions, and wt mice
of strain 129, respectively.
also present. Iron stains of spleen sections from wt mice reveal
only trace amounts of iron in macrophages, while the thalas-
semic mice have abundant, heavily stained iron particles in
what appear to be "nurse cells," the macrophages in the center
of an area of erythropoiesis.
In both the bone and bone marrow of skulls and femora,
significant differences were seen between wt and heterozygous
mice. wt mice have thicker cortical bone in their skulls than do
age-matched thalassemic mice. The femora of wt mice also
have a shorter zone of proliferation and a longer zone of
osteogenesis compared to those from thalassemic mice; this
may contribute to the growth retardation seen in thalassemic
mice. Relative to wt, mice heterozygous for the deletion have
increased bone marrow cellularity as well as increased numbers
of megakaryocytes and erythroid precursors.
In the older animals (5-6 months), histologic studies of the
heterozygous and wt animals show that the spleen is still the
major affected organ. The histologic differences are similar to
those seen in younger animals, except that splenic iron deposits
are significantly increased in the thalassemic mice, and iron
deposits are now observed in both red and white pulp. The
thalassemic mice have abnormal iron accumulation in the
proximal convoluted tubules of their kidneys. This is not seen
in wt mice and is indicative of hemolysis comparable to that
seen in human thalassemic patients. Liver iron stores/deposits,
which are minimal in wt animals, are abundant in both the
hepatocytes and Kupffer cells of thalassemic animals (Fig. 4).
Iron Deposits. Our study provides clear evidence of spon-
taneous iron deposition in the 03-thalassemic mice. Spontane-
ous iron overload in nontransfused human thalassemia pa-
tients arises not from an intrinsically flawed iron regulation or
from an excess of dietary iron but rather from a response to the
abnormal stimulation of increased erythropoietic activity (16-
18).
Iron deposition is evident in mice heterozygous for the bl
and b2 deletions, even at a young age (4-5 weeks), in both
livers and spleens. Iron accumulation in these organs was
a Tb
,~~,,,C .
FIG. 3. Histology of spleens from a heterozygous F1 f3-thalassemic
mouse and a wt littermate. Hematoxylin and eosin staining of spleen
from a 6-week-old wt mouse (a) and a 6-week-old mouse heterozygous
for the bi and b2 deletions (b). (x100.)
progressive. Garrick et al. (17) observed that iron deposition
increases with age until plateaus in iron density and total iron
content are reached at 200 days of age in Hbbth-l homozygotes.
Raja et al. (18) found that liver iron deposition increases in
Hbbth-I homozygotes until the age of 7-8 weeks, but it shows
no further increase over successive weeks.
Hemosiderosis is the result of translocation of iron from the
hemoglobin of red cells into the cells of the reticuloendothelial
system in liver, spleen, and bone marrow. Normally, siderosis
is innocuous and reversible and is even seen as a seasonal
phenomenon in some animal species (19). However, contin-
uous accumulation of iron in liver parenchymal cells can have
deleterious effects. Although in humans iron overload occurs
mainly in hypertransfused thalassemic patients, it can occur in
young thalassemic patients before any transfusional therapy
(20, 21). In these individuals, iron particles are mainly seen in
periportal liver parenchymal cells.
Comparison of Mouse Models of 3-Thalassemia. Mice
heterozygous for the bi and b2 deletions (which we propose to
designate Hbbth-3) have similar, although more severe, abnor-
malities in their hematologic parameters and pathologic and
histologic findings to those of mice homozygous for the Hbbth-I
mutation (7). Mice homozygous for insertional disruption of the
bi gene (Hbbth-2/Hbbth-2) have a more severe phenotype than
that of the heterozygous Hbbth-3/Hbbs mice or than that of
Hbbth-l/Hbbth-l mice homozygous for the bi deletion (8). The
relative severities of the three conditions are of some interest.
The severity of f3-thalassemia is directly related to the imbal-
ance in synthesis between a- and 13-globins and so to the excess
amount of a-globin produced (22). In normal strain 129 mice,
there are two bi and two b2 genes; the two b2 genes produce
-20% of all ,B-globin chains (5). In the absence of any
compensatory and competitive effects, mice homozygous for
the Hbbth-l bi deletion or the Hbbth-2 bl disruption would be
expected therefore to have only 20% of normal ,B-globin
FIG. 4. Histology of spleen, kidney, and liver from F1 heterozygous 3-thalassemic mice. Iron staining of spleen (a), kidney (b), and liver (c)
from a 5-month-old F1 mouse heterozygous for the bi and b2 deletions. Dark stained particles within cells are iron deposits. (X400.)
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production, while mice heterozygous for the Hbbth-3 bi and b2
deletions would be expected to have -50% of normal ,B-globin
synthesis. However, in practice mice homozygous for the
Hbbth-I mutation (which have only the two adult b2 genes)
produce more ,B-globin than expected (-75% of normal rather
than the expected 20%) (23), while mice homozygous for the
Hbbth-2 mutation do not survive and probably produce less
,B-globin than the expected 20% (B. M. Brunner-Jackson,
W. R. Shehee, O.S., and J. B. Whitney, unpublished data).
These altered expressions have been attributed to translational
competition between a- and ,B-globin mRNAs and/or tran-
scriptional competition for access to the locus control region
among all promoters (globin and nonglobin) in the ,B-globin
locus (8, 24). In Hbbth-l/Hbbth- mice, the b2 gene promoter has
no competitor, while in Hbbth-2/Hbbth-2 mice the b2 gene
promoter has both the neo gene promoter and the nonpro-
ductive bl gene promoter as competitors. In our Hbbth-3 mice,
with the deletion of both bi and b2 genes, any compensatory
and/or competitive factors within the 13-globin gene locus are
eliminated.
CONCLUSION
Mice heterozygous for the Hbbth-3 deletion generated in this
study have a similar yet more severe phenotype than mice
homozygous for the Hbbth-l deletion or heterozygous for the
Hbbth-2 insertion. The Hbbth-3 heterozygotes have anemia,
splenomegaly, and bone abnormalities similar to those of
human f30-thalassemic heterozygotes. However, unlike most
untransfused human thalassemics, the animals develop spon-
taneous iron deposits very early. The animals should conse-
quently be-useful not only for studying the pathophysiology of
thalassemias but also for studying iron overload in different
organs. They have the potential of being useful for testing new
ways of treating these diseases and the accompanying iron
overload. In addition, the heterozygotes will be useful for
mating with appropriate transgenic animals to generate a
potentially improved mouse model of sickle cell anemia. Mice
homozygous for the Hbbth-3 deletion may be valuable in
developing in utero therapies for the treatment of severe and
lethal forms of thalassemia.
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